The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
Lack of technology transfer stands out as a formidable barrier
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
Subscribe To Our Newsletter & Stay Updated
